Diane S Aschenbrenner Selected Research

Diane S Aschenbrenner Research Topics

Disease

12	Neoplasms (Cancer) 01/2023 - 09/2017
5	Type 2 Diabetes Mellitus (MODY) 01/2023 - 11/2016
5	Heart Failure 01/2023 - 01/2020
5	COVID-19 11/2021 - 01/2020
4	Asthma (Bronchial Asthma) 01/2023 - 07/2016
3	Chronic Renal Insufficiency 01/2023 - 01/2021
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2022 - 01/2021
3	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 06/2018
2	Kidney Diseases (Kidney Disease) 01/2023 - 01/2021
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2023 - 01/2022
2	Nausea 01/2023 - 01/2023
2	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2022 - 01/2022
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2022 - 01/2022
2	Inborn Genetic Diseases (Disease, Hereditary) 01/2022 - 01/2021
2	Endometrial Neoplasms (Endometrial Cancer) 01/2022 - 11/2021
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022 - 01/2021
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 10/2016
2	Infections 01/2022 - 01/2022
2	Opiate Overdose 01/2022 - 10/2017
2	Seizures (Absence Seizure) 01/2021 - 06/2016
2	Human Influenza (Influenza) 01/2021 - 01/2019
2	Bacterial Pneumonia 12/2019 - 10/2019
2	Heart Diseases (Heart Disease) 01/2019 - 06/2018
2	Hemorrhage 12/2016 - 06/2016
1	Febrile Neutropenia 05/2024
1	Sepsis (Septicemia) 03/2024
1	Sleepiness 01/2023
1	Major Depressive Disorder (Major Depressive Disorders) 01/2023
1	Constipation 01/2023
1	Epilepsy (Aura) 01/2023
1	Substance-Related Disorders (Drug Abuse) 01/2023
1	Vomiting 01/2023
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2023
1	Diarrhea 01/2023
1	Skin Diseases (Skin Disease) 01/2023
1	Hepatorenal Syndrome 01/2023
1	Dizziness (Lightheadedness) 01/2023
1	Osteoporosis 01/2023
1	Hyperhidrosis 01/2023
1	Hypocalcemia 01/2023
1	Headache (Headaches) 01/2023
1	Migraine Disorders (Migraine) 01/2023
1	Prurigo 01/2023
1	Ototoxicity 01/2023
1	Vitiligo 11/2022

Drug/Important Bio-Agent (IBA)

9	Monoclonal AntibodiesIBA 10/2022 - 03/2016
3	dupilumabIBA 01/2023 - 10/2019
3	pembrolizumabIBA 01/2022 - 11/2019
3	Anti-Bacterial Agents (Antibiotics)IBA 12/2019 - 12/2017
2	Nasal SpraysIBA 01/2023 - 01/2019
2	finerenoneIBA 01/2023 - 11/2021
2	AntiemeticsIBA 01/2023 - 05/2018
2	PlatinumIBA 01/2023 - 01/2021
2	Budesonide (Pulmicort)FDA LinkGeneric 01/2023 - 01/2022
2	ruxolitinibIBA 11/2022 - 01/2022
2	ErbB Receptors (EGF Receptor)IBA 01/2022 - 01/2021
2	olaparibIBA 01/2022 - 01/2020
2	Antiviral Agents (Antivirals)IBA 01/2021 - 01/2019
2	Hypoglycemic Agents (Hypoglycemics)IBA 01/2021 - 01/2020
2	remdesivirIBA 01/2021 - 01/2020
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2024
1	TerlipressinIBA 01/2023
1	4-phenylbutyric acid (Buphenyl)FDA Link 01/2023
1	Counterfeit DrugsIBA 01/2023
1	Dextromethorphan (Racemethorphan)FDA LinkGeneric 01/2023
1	ursodoxicoltaurineIBA 01/2023
1	ElectrolytesIBA 01/2023
1	Denosumab FDA Link 01/2023
1	Furosemide (Lasix)FDA LinkGeneric 01/2023
1	sodium thiosulfate FDA Link 01/2023
1	Cisplatin (Platino)FDA LinkGeneric 01/2023
1	sodium phenylbutyrate and taurursodiolIBA 01/2023
1	Bupropion (Wellbutrin)FDA LinkGeneric 01/2023
1	terlivazIBA 01/2023
1	mirvetuximab soravtansineIBA 01/2023
1	Opioid Analgesics (Opioids)IBA 01/2023
1	Albuterol (Salbutamol)FDA LinkGeneric 01/2023
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2023
1	capmatinibIBA 12/2022
1	ibrutinibIBA 12/2022
1	trastuzumab deruxtecanIBA 12/2022
1	human ERBB2 proteinIBA 12/2022
1	Anaplastic Lymphoma KinaseIBA 11/2022
1	CrizotinibIBA 11/2022
1	Janus Kinase InhibitorsIBA 11/2022
1	duvelisibIBA 10/2022
1	ofatumumab FDA Link 10/2022
1	EdaravoneIBA 01/2022
1	taxaneIBA 01/2022
1	tisotumab vedotinIBA 01/2022
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2022
1	vosoritideIBA 01/2022

Therapy/Procedure

11	Therapeutics 01/2023 - 06/2016
3	Drug Therapy (Chemotherapy) 01/2022 - 01/2021
3	Injections 07/2017 - 11/2016
2	Castration 01/2022 - 06/2018
1	Catheters 03/2024
1	Renal Dialysis (Hemodialysis) 03/2024
1	Subcutaneous Infusions 01/2023